Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 13, 2008, doi:10.1212/01.wnl.0000304046.23960.25)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz
Right arrow CME: Take the course for this article:
Volume 71, Number 3, July 15, 2008
Right arrow All Versions of this Article:
01.wnl.0000304046.23960.25v1
71/3/164    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Ghaffar, O.
Right arrow Articles by Feinstein, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghaffar, O.
Right arrow Articles by Feinstein, A.
Related Collections
Right arrow All Neuropsychology/Behavior
Right arrow Attention
Right arrow All Psychiatric disorders
Right arrow Multiple sclerosis
NEUROLOGY 2008;71:164-169
© 2008 American Academy of Neurology

Multiple sclerosis and cannabis

A cognitive and psychiatric study

Omar Ghaffar, MD, FRCP(C) and Anthony Feinstein, MPhil, PhD, FRCP(C)

From the Neuropsychiatry Program, Department of Psychiatry, Sunnybrook Health Sciences Centre and University of Toronto, Canada.

Address correspondence and reprint requests to Anthony Feinstein, Department of Psychiatry, Sunnybrook Health Sciences Centre, FG08-2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5

Background: A significant minority of patients with multiple sclerosis (MS) use cannabis, yet no study has examined the possible effects on mentation. Here, we report the emotional and cognitive correlates of street cannabis use in patients with MS.

Methods: A sample of 140 consecutive patients with MS were interviewed with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I disorders (SCID-IV) from which details of cannabis use were recorded. Cognition was assessed using the Neuropsychological Battery for MS supplemented with the Symbol Digit Modalities Test (SDMT), an index of information processing speed, working memory, and sustained attention.

Results: Ten subjects (7.7%) were defined as current cannabis users based on use within the last month. Compared to non-cannabis users (n = 130), they were younger (p = 0.001). Each of the 10 current cannabis users was matched on demographic and disease variables to four subjects with MS who did not use cannabis (total control sample n = 40). Group comparisons revealed that the proportion of patients meeting DSM-IV criteria for a psychiatric diagnosis was higher in cannabis users (p = 0.04). In addition, on the SDMT, cannabis users had a slower mean performance time (p = 0.006) and a different pattern of response compared to matched controls (group x time interaction; p = 0.001).

Conclusions: Inhaled cannabis is associated with impaired mentation in patients with multiple sclerosis, particularly with respect to cognition. Future studies are required to clarify the direction of this relationship.

GLOSSARY: 7/24 = 7/24 Spatial Learning Test; BSS = Beck Suicide Scale; COWAT = Controlled Oral Word Association Test; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders; EDSS = Expanded Disability Status Scale; HADS = Hospital Anxiety and Depression Scale; MS = multiple sclerosis; NPBMS = Neuropsychological Battery for MS; PASAT = Paced Auditory Serial Addition Task; SCID-IV = Structured Clinical Interview for DSM-IV Axis I disorders; SDMT = Symbol Digit Modalities Test; SRT = Selective Reminding Test; SSSI = Social Stress and Support Inventory.


ant.feinstein{at}utoronto.ca

Editorial, page 160

e-Pub ahead of print on February 13, 2008, at www.neurology.org.

The study was funded by grant 15001 from the Canadian Institutes for Health Research (CIHR). O.G. is supported by a CIHR Fellowship.

Disclosure: O.G. has received honoraria from Cerebrio, a continuing medical education company. A.F. has received lecture honoraria from Berlex Canada, Serono Canada, Serono USA, Teva Neuroscience, and Avanir Pharmaceuticals.

Received July 30, 2007. Accepted in final form October 30, 2007.


Related articles in Neurology:

Cannabis bliss?: Perhaps not?
Peter A. Arnett
Neurology 2008 71: 160-161. [Full Text]  



This article has been cited by other articles:


Home page
NeurologyHome page
P. A. Arnett
Cannabis bliss?: Perhaps not?
Neurology, July 15, 2008; 71(3): 160 - 161.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Multiple sclerosis and cannabis. A cognitive and psychiatric study
Lambros Messinis, et al.
Neurology Online, 8 May 2008 [Full text]
Reply from the authors
Anthony Feinstein, et al.
Neurology Online, 8 May 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.